GVR Report cover Electronic Clinical Outcome Assessment Solutions Market Size, Share & Trends Report

Electronic Clinical Outcome Assessment Solutions Market Size, Share & Trends Analysis Report By Delivery Mode (Web & Cloud Based, On-premise), By End User, By Region, And Segment Forecasts, 2022 - 2030

  • Report ID: GVR-1-68038-440-6
  • Number of Pages: 140
  • Format: Electronic (PDF)
  • Historical Range: 2017 - 2020
  • Industry: Healthcare

Report Overview

The global electronic clinical outcome assessment solutions market size was valued at USD 1.22 billion in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 14.8% from 2022 to 2030. An increasing number of clinical trials, the need to improve compliance, effectively capture and manage clinical information, the need to reduce costs, and an increase in R&D activities, are projected to drive the growth of the market. In December 2020, Kayentis— a French company specializing in electronic clinical outcome assessment (eCOA) solutions received funding of about USD 8.3 million. This facilitated its objectives for regional expansion and product development.

U.S. electronic clinical outcome assessment solutions market size, by end user, 2020 - 2030 (USD Billion)

The COVID-19 pandemic adversely impacted the conduction and management of clinical trials in 2020. However, market stakeholders implemented several measures such as adoption of eClinical solutions to overcome these challenges and to ensure continuity of clinical research activities. The pandemic thus helped catalyze the digitalization of clinical trials. Many sponsors, biopharma companies, medical device firms, & CROs began adopting eClinical solutions to collect data, manage it, and draw useful insights effectively and remotely. eCOAs support collection of patient data remotely.

The rising adoption of eCOA by medical research professionals is driving the market growth. With the rising number of research studies, the need for a centralized data capture system that helps improve patient engagement is also increasing. This is anticipated to fuel market demand over the forecast period. The use of electronic patient reported outcomes (ePROs) has emerged as a helpful tool during the pandemic to collect and share important trial data, and to use other embedded tools such as alerts and reminders to weave the trial into the daily lives of patients. Technological advancements such as Alexa-style tools, reward features, and gamification are estimated to enhance eCOA products thus driving the market growth in the future.

The rising burden on pharmaceutical manufacturers to cut down overall costs for new drug development procedures has resulted in their rising inclination toward electronic data capturing from paper-based procedures. The data capturing via eCOA platforms improve the quality of the information received, harmonizes the data collection procedures, and offers significant value to its users, such as data analysis. Electronic-based services for data capturing & analyzing meet all the challenges of paper-based records, with an increase in patient compliance. They also eliminate the risk of data variance and minimize the site monitoring cost. Streamlined information offered by these solutions helps improvise the data quality by collecting the information in a structured way. These aforementioned benefits of using eCOA are expected to drive the demand for products in the coming years. 

Delivery Mode Insights

Web & cloud-based segment contributed to the largest revenue share of the market by delivery mode in 2021. This is owing to the associated benefits of its usage. Remote access to the patient’s health information and sharing of information to limit potential misuse of data or address the problems at a critical point of study are some of the key features offered by these solutions. Other benefits include centralization of data, scalability, reduced costs, and uptime consistency.

On-premise solutions, on the other hand, are preferred for their localization of data, data security, and more control over data. The high cost of implementation and infrastructure may restrain the segment growth. An increasing number of companies and initiatives deployed by them are expected to fuel market growth. Some of the key companies include IBM, IQVIA Inc., Medidata Solutions, Inc., Clario, ArisGlobal, Signant Health, and others.

End-user Insights

Contract Research Organizations (CROs) held the largest revenue share in 2021 and are expected to witness significant growth in the near future due to the outsourcing of clinical research management by major biopharmaceutical and medical device companies. IQVIA eCOA for example supports real-time patient data collection in real-world studies and clinical research. During the COVID-19 the solution was deployed across several trials to enable real-time data capture, cost-effectively, and remotely.

Global electronic clinical outcome assessment solutions market share, by end user, 2021 (%)

Hospitals and healthcare providers are adopting electronic data capturing services to improve patient engagement in research studies, as eCOA digitally collects the information from both patients and doctors. eCOA captures information on handheld devices such as smartphones & tablets, interactive voice response systems, browsers, and patients’ Bring-Your-Own-Device (BYOD). It utilizes secure systems that meet the regulatory guidelines for capturing clinical data. The adoption of mHealth devices and the introduction of advanced technologies for patient care, such as BYOD, are the key growth propellers for the implementation of eCOA solutions in hospitals.

Regional Insights

North America was estimated to be the largest regional market in 2021. The presence of technologically advanced research centers, medical device manufacturers, universities, and hospitals coupled with improved healthcare establishments are expected to drive the new drug development activities in the coming years. The U.S. accounted for the largest market share of North America in 2021, owing to the higher adoption levels of eClinical solutions. Initiatives pertaining to the adoption of eClinical platforms undertaken by key end users are anticipated to boost the usage in the coming years.

Asia Pacific is growing in terms of large patient pool, outsourcing, and flow of investment by MNCs and CROs to support clinical research and drug discovery. This is projected to enhance the market growth. India and China are the key markets for clinical research outsourcing for major pharma & biotech companies. This is anticipated to be a key contributing factor to the rising demand for eCOA solutions over the forecast period.

Key Companies & Market Share Insights

The electronic clinical outcome assessment solutions market is competitive with the presence of many companies. These are involved in implementing strategic initiatives that include upgradation of software and services, customer acquisition, partnerships & collaborations, mergers & acquisitions, and sales & marketing activities. For instance, in June 2021, Assistek launched an upgraded version of its cloud-based eCOA platform. The upgraded version includes enhancements for clinical teams, sponsors, patients, and CROs. It is designed to align with best practices for collection of clinical outcomes securely. IBM Clinical Development suite on the other hand offers a comprehensive solution for clinical data management serving a wide range of user types. It includes eCOA that replaces standard reporting methods and enhances clinical outcomes. Some of the key players in the global electronic clinical outcome assessment solutions market include:

  • IBM

  • IQVIA Inc.

  • Medidata Solutions, Inc.

  • Clario

  • ArisGlobal

  • Signant Health

  • TransPerfect

  • Cloudbyz

  • Climedo Health GmbH

  • ClinCapture

Electronic Clinical Outcome Assessment Solutions Market Report Scope

Report Attribute


The market size value in 2022

USD 1.36 billion

The revenue forecast in 2030

USD 4.12 billion

Growth Rate

CAGR of 14.8% from 2022 to 2030

Base year for estimation


Actual estimates/Historical data

2017 - 2020

Forecast period

2022 - 2030

Quantitative units

Revenue in USD million & CAGR from 2022 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Delivery mode, end user

Regions covered

North America; Europe; Asia Pacific; Latin America; MEA

Country Scope

U.S.; Canada; U.K.; Germany; Italy; France; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; South Africa; Saudi Arabia

Key companies profiled

IBM; IQVIA Inc.; Medidata Solutions, Inc.; Clario; ArisGlobal; Signant Health; TransPerfect; Cloudbyz; Climedo Health GmbH; ClinCapture

Customization scope

Free report customization (equivalent to up to 8 analyst working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report 

This report forecasts revenue growth at the regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2017 to 2030. For this report, Grand View Research has segmented the global electronic clinical outcome assessment solutions market based on delivery mode, end-user, and region:

  • Delivery Mode Outlook (Revenue, USD Million, 2017 - 2030)

    • On-premise

    • Web & Cloud-based

  • End-User Outlook (Revenue, USD Million, 2017 - 2030)

    • Hospitals/Healthcare providers

    • CROs

    • Pharmaceutical and Biotechnology Firms

    • Medical Device Companies

    • Others

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • India

      • Japan

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

    • MEA

      • South Africa

      • Saudi Arabia

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.